🧫
experiment

Identified a subtype of Sox6+ Anxa1+ dopaminergic neurons that are selectively lost earlier than other DANs in MitoPark mice, with loss aligning with motor symptom development.

🧫 Experiment Protocol NeuropathologyParkinson's diseaseANXA1mouseextracted
Characterization study using MitoPark mouse model of PD; subtype identified via molecular markers
PRIMARY OUTCOME
Identified a subtype of Sox6+ Anxa1+ dopaminergic neurons that are selectively lost earlier than other DANs in MitoPark mice, with loss aligning with motor symptom development.
LINKED HYPOTHESES
Source: pmid_39763754
🧫 Experiment Extras
PATHWAY
dopaminergic signaling
MARKET PRICE
$0.50
STATUS
extracted
Related Target
ANXA1composite 0.556
View on SciDEX ↗